Ledger.Open graph →
SEC Form D · Amendment · filed May 27, 2022

Aquyre Biosciences Inc

Offering
$5.5M
Sold
$5.4M
Exemption
Rule 506(b)
Industry
Other
Location
BOSTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Ari Azhir · Boston, MADirectorBertrand Le Conte Chrestien De Poly · Boston, MAExec · DirectorAldo Maccari · Boston, MADirectorAurelio Fernandez · Boston, MADirectorThierry Thaure · Boston, MAExec · DirectorRonald W. Chilton · White Plains, NYDirectorJesse Shrader · PORTLAND, ORExec · DirectorScott A. Snow · White Plains, NYExec · Directorvan Biema & Company, LLC · NEW YORK, NYDirectorAnthony Potdevin · PORTLAND, ORDirectorEmanuele Conti · SAN FRANCISCO, CADirectorGuilherme Cherman Perdigao De Oliveira · Syracuse, NYExec · DirectorCarl Ager · SALT LAKE CITY, UTDirectorWillard `. Mast · Grandview, TXDirectorRoman `. Miller · Grandview, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗